Hermann Einsele

Papers

Total Citations

H-Index

About

Hermann Einsele is a leading figure in hematology and oncology, renowned for his transformative contributions to the treatment of multiple myeloma and other hematologic malignancies. His research has fundamentally advanced the use of immunotherapeutic strategies, particularly bispecific antibodies and CAR T-cell therapy, establishing new standards for patient care. Einsele’s work has been pivotal in understanding and managing infectious complications in immunocompromised patients, especially regarding viral infections after stem cell transplantation. With over 800 published papers and more than 50,000 citations, his impact on the field is profound. He has led numerous landmark clinical trials that have shaped current treatment paradigms, including the development of the first bispecific T-cell engager approved for multiple myeloma. Einsele has also served as president of the European Society for Blood and Marrow Transplantation (EBMT), reflecting his leadership in the global hematology community. His dedication to translating bench discoveries into bedside innovations continues to inspire a new generation of researchers and clinicians.